Total cholesterol affects the outcome in anterior cerebral artery-occluded acute ischemic stroke patients treated with thrombolysis

Lei Niu,Shaowei Jiang,Yang Wang,Ya Peng,Aihua Fei,Hai-rong Wang,Yi Li,Jingchen Zhang,Connor Meaney,Chengjin Gao,Shuming Pan

DOI: https://doi.org/10.21203/rs.2.11048/v1

2019-07-06

Abstract:Abstract Object In this study, we investigated whether certain types of lipid profiles are major contributors to disease outcomes. Methods At two stroke medical centers, among 13,285 hospitalized patients treated with thrombolysis, thrombectomy, or conventional care, two hundred and seventy-six anterior cerebral artery-occluded acute ischemic stroke (AIS) patients were screened. We examined the plasma lipid profiles by using the cutoff values from a receiver operating characteristic (ROC) curve. A multivariate logistic regression or Fisher’s exact test was used to compare the outcome and risk events. The modified Rankin scale (mRS) score was used to assess the major clinical outcome of the patients 3 months after disease onset. Mortality and symptomatic intracranial hemorrhage (sICH) were both evaluated as risk factors. The disease outcome was examined by analyzing symptom improvement at discharge. Results In the anterior cerebral artery-occluded AIS (NIHSS ≥ 10) patients treated by intravenous (IV) thrombolysis, a total cholesterol (TC) level greater than 5.07 mmol/L predicted a poor outcome (OR 3.55, 95% CI 1.21,10.46, p = 0.021). Conclusion In anterior cerebral artery-occluded AIS patients, the TC level is a highly promising screening factor for predicting the outcome of IV thrombolysis.